HOMESeminars & Presentations2017 Organizer Seminars / Sponsor Seminars / Luncheon Seminars

Co-located Exhibition:

Sign Up to Our Newsletter:

Sponsors' Microsites

Press Releases

From the Organizer
- Change of Booth No.
Research Center for Medical Plant Resources National Institutes of Biomedical Innovation Health and Nutrition: D-13

10/10

National Center Biobank Network ― Introduction to 6NC―

Lonza Cell & Gene Therapy Manufacturing Facility in Houston, TX, Area to Complete Construction on Schedule in 2017

Lonza to Increase and Expand Capabilities for Drug Product Services for Parenteral Dosage Forms

Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development

10/6

SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services
SIRION Biotech (Bavarian Pavilion: D06)
SIRION and Vibalogics

9/29

Press release Dutch Food CRC NIZO presents microbiome capability with the Holland Pavilion at BioJapan 2017.

9/26

INCJ and 9 portfolio companies in the health and medical field to jointly exhibit at BioJapan 2017

Development of Rehabilitation system based on real-time electroencephalogram analysis

Production of genetic test strip enabling simple infectious diseases test and export to ASEAN countries

9/25

【AIST Sponsor Seminar】Challenge to merging digital and biotechnologies

9/11

Inauguration of Shonan Research Center

CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research

Takeda Announces the Start of Operations for AXCELEAD at its Shonan Research Center

Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors

9/1

【Exhibitor Presentation】IT changes drug developments / Device technologies of AIST

8/14

DefiniGEN announces collaboration with Kishida Chemical to develop their iPSC-derived disease model business in the Japanese pharmaceutical market

2017 Organizer Seminars /
Sponsor Seminars /
Luncheon Seminars

Oct. 11 (Wed.)

Oct. 12 (Thu.)

Oct. 13 (Fri.)

Keynote Lectures

Date & Time: Oct. 11 (Wed.) 10:00-11:30
Venue: Annex Hall F203-206

Connecting Digital and Bio Technology for Future Innovation
- Toward the Realization of “Society 5.0” -

Toshiaki Higashihara

President & CEO, Hitachi
(Vice Chairman, Japan Electronics and Information Technology Industries Association)

Gladys H. Monroy

BioScience and Technology development in Singapore, Policy and Outcome

David Lane

Chief Scientist, A*STAR; Director, p53 Lab

The Future of Pharmaceutical Innovation

Yoshihiko Hatanaka

President,
Japan Pharmaceutical Manufacturers Association

■Organizer Seminar

■Luncheon Seminar

*Visitor registration is required to attend the seminars.

*Special sessions and Organizer seminars are subject to a fee of 5,000 yen (Fee covers all three days. Fee does not apply to Partnering participants).

*The program is subject to change.

Oct.10 (Tue.)

F201 F202 F203 F204 F205 F206
9:00-
18:00

Oct. 11(Wed.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

Opening Ceremony

Simultaneous
Interpretation

10:00-
10:30

<Keynote Speech>

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00
12:00-
12:30

CLOSED

【L-1】 Government of Canada

The 8th Canada Life Sciences Seminar @ BioJapan "Novel Approaches to Address Unmet Medical Needs in Neurodegenerative Disorders --- Opportunities in Canada for Investment, Innovation and Business"

英語進行

CLOSED

【L-2】 Bayer Yakuhin

Joining forces with Bayer in Drug Discovery & Development

Simultaneous
Interpretation

12:30-
13:00

【O-1】 Life-Innovation Forum - Current Status and Issues on Policies for Medical Innovation

Simultaneous
Interpretation

13:00-
13:30
13:30-
14:00
14:00-
14:30
14:30-
15:00

Japan Bioindustry Award, Bioindustry Research Award 2017
Ceremony, Award Lecture and Poster Session

Simultaneous
Interpretation

15:00-
15:30

【O-2】 Industrialization of Regenerative Medicine in Asia-Pacific region

Simultaneous
Interpretation

英語進行

15:30-
16:00

【O-3】 Bioeconomy Strategies Around the World

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 12(Thu.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

【O-4】 Bio-cluster summit 2017

Simultaneous
Interpretation

【O-5】 Cancer immunotherapy targeting immune regulatory mechanisms

Simultaneous
Interpretation

<Special Session>Solutions provided by KANEKA using Biotechnology

Simultaneous
Interpretation

10:00-
10:30

【O-6】 Evolutional findings/technology in Microbiology ~Toward next generation~

Simultaneous
Interpretation

10:30-
11:00
11:00-
11:30
11:30-
12:00

CLOSED

【O-7】 Gene Therapy Update
― Commercialization of CAR-T and TCR-T gene therapy; Progress and Challenges ―

Simultaneous
Interpretation

12:00-
12:30

【L-3】 Germany Trade and Invest

Make the most of your research and development partnerships - Find your German match

Simultaneous
Interpretation

CLOSED

【L-4】 Nikon CeLL innovation / Lonza Japan

Development of cGMP compliant manufacturing processes that ensure safety and quality of Cell Therapy/Gene Therapy products for regenerative medicine: our approach and experience

Simultaneous
Interpretation

CLOSED

【L-5】 Takeda Pharmaceutical

The establishment of Drug Discovery Ecosystem by partnership with industry, government and academia

Simultaneous
Interpretation

Japanese
Session

12:30-
13:00
13:00-
13:30
13:30-
14:00

CLOSED

【O-8】 Forefront of biopharmaceutical manufacturing
-Continuous production technology enabled by advanced ICT technology-

Simultaneous
Interpretation

14:00-
14:30
14:30-
15:00
15:00-
15:30

CLOSED

【O-9】 R&D of RM products in Japan

Simultaneous
Interpretation

【O-11】 Reality and Challenge of Medical Big Data

Simultaneous
Interpretation

15:30-
16:00

【O-10】 Industrial creations by ecosystem control - new avenues opened by omics technologies -

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

Oct. 13(Fri.)

F201 F202 F203 F204 F205 F206
9:30-
10:00

【O-12】 Go for intensify of "Foods with Function Claims" system ~ What is evidence data that should be conveyed to consumers?

Japanese
Session

CLOSED

【O-13】 Update on iPS cell’s Research and Innovation

Simultaneous
Interpretation

10:00-
10:30
10:30-
11:00
11:00-
11:30

【O-14】 Present and Perspective of microbiome science in the maintenance and control of human health

Simultaneous
Interpretation

【O-15】 What Pharma needs to do in an era of degital with a changing healthcare ecosystem

Simultaneous
Interpretation

11:30-
12:00
12:00-
12:30

CLOSED

【L-6】 1st RORZE LifeScience Seminar

Application of human iPS cells for drug discovery

Japanese
Session

CLOSED

【L-7】 Metabolon

Precision Metabolomics™ Illuminates New Paths for Medicine and Pharmaceutical R&D

英語進行

12:30-
13:00
13:00-
13:30
13:30-
14:00
14:00-
14:30
14:30-
15:00
15:00-
15:30

【O-16】 Food, Agriculture and Fishery Industries and its Value Chain with using AI and IoT

Simultaneous
Interpretation

【O-17】 Genome editing legal aspect and industrial application now and future

Genome editing regulatory considerations and industrial application now and future

Simultaneous
Interpretation

【O-18】 Innovate Healthcare in Aging Society!!

Simultaneous
Interpretation

【O-19】 Emerging technologies and products in Regenerative Medicine

Simultaneous
Interpretation

15:30-
16:00

【O-20】 Recent progress in development of nucleic acid therapeutics

Simultaneous
Interpretation

16:00-
16:30
16:30-
17:00
17:00-
17:30

TOPへ戻る

| Sitemap |

© 2017 JTB Communication Design, Inc. All rights reserved.